we performed cardiac blood-pool scintigraphy using technetium-99m diethylenetriaminepentaacetic acid human serum albumin [ ( 99mtc ] dtpa-hsa ) , a newly developed blood-pool agent , in 31 patients with various heart diseases and evaluated its clinical usefulness in comparison with the conventional in vivo 99mtc red blood cell ( rbc ) labeling .
C0018787
cardiac
C0018799
heart diseases